Investing in the expansion and strengthening of technological platforms and analytical platforms is essential to expand society's access to new and modern products, services and strategic technologies for health. This investment in strengthening and developing skills and infrastructure is the basis for our research, development and innovation efforts. To this end, Bio-Manguinhos has focused its initiatives on the consolidation and implementation of technological platforms based on Technological Development and Technology Transfer, which also involve collaboration with national and international partners.

Technology Platforms 

• Expression systems in superior eukaryotes (lineage cells);

• Expression systems in prokaryotes and lower eukaryotes (E. coli and yeast);

• Production system in eukaryotic cells (CHO, MRC5, VERO, SP2/0 cells);

• Production system in primary cells (chicken fibroblast);

• Production system in prokaryotes and lower eukaryotes (bacteria and yeast);

• Fill&Finish processing systems for vaccines and biopharmaceuticals (formulation, packaging, lyophilization, crimping, visual inspection, labeling and packaging);

• Conjugation of polysaccharides and proteins;

• Monoclonal antibodies.

Analytical Platforms

• Immunofluorescence;

• Immunochromatography;

• Enzyme Immunoassays;

• Immunophenotyping Assays;

• Molecular Assays; 

• Microarrays.